2nd Quarter - Report — STRYKER CORPORATION for STRYKER CORPORATION (2014)

Firm

STRYKER CORPORATION

Client

STRYKER CORPORATION

Income

—

Expenses

$50,000

Expense method

C: businesses, Internal Revenue Code section 162(e)

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

S 232, the Medical Device Access and Innovation Protection Act and H.R. 523, the Protect Medical Innovation Act - to repeal the 2.3% excise tax on medical devices Legislation to make the R&D tax credit permanent

Lobbyist	Covered position, as disclosed
PAGE KRANBUHL	Senate HELP Subcommittee staff
NATHANIEL FRANK TIPTON New	—

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 523 (113th)

Medicare/Medicaid MMM

Implementation of Public Law 111-148, the Patient Protection and Affordable Care Act, particularly accountable care organizations and bundled payment models Discussed appropriate Medicare inpatient hopspital MS-DRG assignments

Lobbyist	Covered position, as disclosed
PAGE KRANBUHL	Senate HELP Subcommittee staff
ERIC RUGO	—

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Implementation of Public Law 112-144: The Food and Drug Administration Safety and Improvement Act, in particular the custom device provision H.R. 3303, the Software Act - FDA regulation of health information technology and mobile medical applications

Lobbyist	Covered position, as disclosed
PAGE KRANBUHL	Senate HELP Subcommittee staff
NATHANIEL FRANK TIPTON New	—

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 3303 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.